Considering the options
A message from Editor in Chief Marc B. Garnick, M.D.
This issue of Perspectives on Prostate Disease marks the end of our first full year of publication, a milestone worthy of celebration. And we at Harvard Health Publications have much to celebrate "" dedicated staff and editorial board members, a committed production team, and leadership devoted to publishing a highly readable, well-researched periodical that delves into the complexities of prostate diseases. I extend my sincere thanks to Ann MacDonald, who helped launch the publication and ably edited the first three issues, and welcome Suzanne Rose, who assumed the role of editor in August.
I also want to thank the subscribers who responded to the reader survey that accompanied the previous issue of Perspectives. Although we are still receiving replies, we have been gratified to learn that we're hitting the mark when it comes to offering the type of information you want on prostate diseases. Many readers suggested topics for articles, such as brachytherapy (a type of radiation therapy) and intermittent hormone therapy, and we plan to address them in future issues. We also received requests to include more statistics about the likelihood of side effects from medications and treatment; more information on nutrition; and more brief reports on the latest research findings, which we've done in the "Advances and breakthroughs" section of this issue. We appreciate the feedback, and we will continue to incorporate your thoughtful suggestions.